Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Shmuel Yaccoby

Concepts (332)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
63
2023
2915
4.970
 Why?
Osteoclasts
17
2015
424
2.560
 Why?
Bone Diseases
7
2014
97
2.310
 Why?
Osteoblasts
13
2012
451
1.490
 Why?
Gene Expression Regulation, Neoplastic
12
2018
824
1.310
 Why?
Osteolysis
6
2013
75
1.260
 Why?
Boronic Acids
12
2013
182
1.210
 Why?
Neoplasm Proteins
6
2018
321
1.210
 Why?
Coculture Techniques
12
2015
143
1.200
 Why?
Mice, SCID
17
2015
173
1.020
 Why?
Bone Marrow Cells
5
2015
190
1.010
 Why?
Cell Differentiation
14
2018
649
0.970
 Why?
Bone and Bones
9
2014
473
0.950
 Why?
Pyrazines
11
2013
187
0.910
 Why?
Bone Marrow
8
2018
351
0.860
 Why?
Cell Proliferation
11
2023
986
0.810
 Why?
Mice
26
2015
5657
0.780
 Why?
Cell Communication
3
2015
69
0.760
 Why?
Intercellular Signaling Peptides and Proteins
4
2010
100
0.710
 Why?
Osteogenesis
5
2012
353
0.700
 Why?
Bone Resorption
4
2011
297
0.680
 Why?
Adipocytes
2
2018
121
0.650
 Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
10
0.640
 Why?
Animals
29
2016
13098
0.620
 Why?
Proteoglycans
4
2008
81
0.610
 Why?
Bone Neoplasms
2
2011
178
0.600
 Why?
Gene Expression
3
2018
612
0.580
 Why?
Humans
62
2023
49877
0.570
 Why?
Antineoplastic Agents
9
2015
1175
0.560
 Why?
Cell Movement
4
2013
245
0.550
 Why?
Neoplastic Stem Cells
1
2017
100
0.540
 Why?
Cell Survival
9
2015
590
0.530
 Why?
Protease Inhibitors
4
2010
58
0.530
 Why?
Tumor Microenvironment
2
2015
221
0.520
 Why?
Cytokines
3
2015
607
0.490
 Why?
Cysteine-Rich Protein 61
1
2014
3
0.470
 Why?
Plasma Cells
6
2009
221
0.450
 Why?
Nicotinamide Phosphoribosyltransferase
1
2013
5
0.430
 Why?
Angiogenesis Inhibitors
3
2010
182
0.420
 Why?
Membrane Glycoproteins
5
2009
244
0.420
 Why?
Protein-Tyrosine Kinases
1
2013
95
0.410
 Why?
Thalidomide
6
2016
374
0.410
 Why?
Mesenchymal Stem Cell Transplantation
1
2012
17
0.400
 Why?
Gene Expression Profiling
7
2023
1028
0.380
 Why?
Parathyroid Hormone
4
2010
147
0.380
 Why?
Up-Regulation
3
2013
446
0.380
 Why?
Wnt Proteins
2
2010
100
0.380
 Why?
Signal Transduction
6
2013
1608
0.350
 Why?
Rabbits
5
2013
376
0.350
 Why?
Receptor, EphB4
1
2009
5
0.330
 Why?
Ephrin-B2
1
2009
5
0.330
 Why?
Placenta
1
2011
129
0.330
 Why?
Fenretinide
1
2009
5
0.330
 Why?
Disease Models, Animal
7
2016
1411
0.330
 Why?
Models, Biological
4
2010
719
0.330
 Why?
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
1
2009
7
0.330
 Why?
Cell Line, Tumor
9
2015
1388
0.330
 Why?
Dipeptides
1
2009
22
0.330
 Why?
Antineoplastic Combined Chemotherapy Protocols
8
2016
994
0.320
 Why?
Cell Adhesion Molecules
1
2009
87
0.320
 Why?
Bone Development
1
2009
64
0.310
 Why?
Tumor Necrosis Factor Ligand Superfamily Member 13
1
2007
3
0.300
 Why?
Transmembrane Activator and CAML Interactor Protein
1
2007
6
0.300
 Why?
Extracellular Matrix Proteins
1
2008
69
0.300
 Why?
Apoptosis
8
2012
1092
0.300
 Why?
Disease Progression
6
2014
820
0.290
 Why?
Bone Remodeling
4
2012
149
0.280
 Why?
Recombinant Fusion Proteins
1
2007
186
0.280
 Why?
Antibodies
1
2006
151
0.260
 Why?
Neoplasm Recurrence, Local
3
2023
626
0.260
 Why?
Immunohistochemistry
5
2015
972
0.260
 Why?
Tumor Cells, Cultured
7
2013
462
0.260
 Why?
Serine Endopeptidases
1
2006
51
0.260
 Why?
RNA, Small Interfering
4
2013
210
0.260
 Why?
Transplantation, Heterologous
5
2009
75
0.250
 Why?
Antigens, Neoplasm
1
2006
146
0.250
 Why?
Prognosis
10
2018
1957
0.240
 Why?
Melphalan
2
2016
173
0.240
 Why?
Severe Combined Immunodeficiency
1
2005
11
0.240
 Why?
Neovascularization, Pathologic
4
2009
153
0.240
 Why?
Alkaline Phosphatase
6
2017
94
0.240
 Why?
NF-kappa B
4
2013
315
0.230
 Why?
Hematopoietic Stem Cells
3
2012
182
0.230
 Why?
Cell Division
5
2004
294
0.220
 Why?
Bone Density
3
2010
384
0.210
 Why?
Positron-Emission Tomography
2
2017
286
0.210
 Why?
Killer Cells, Natural
2
2015
107
0.210
 Why?
Translocation, Genetic
2
2021
263
0.210
 Why?
Stromal Cells
1
2003
72
0.210
 Why?
Transcription Factors
2
2023
565
0.200
 Why?
Immunophenotyping
2
2015
109
0.200
 Why?
Immunotherapy, Adoptive
2
2015
158
0.190
 Why?
T-Lymphocytes
2
2015
328
0.190
 Why?
Cell Line
2
2015
1010
0.190
 Why?
Epigenomics
1
2021
67
0.190
 Why?
Bone Transplantation
4
2010
46
0.180
 Why?
Decorin
2
2012
7
0.180
 Why?
Antibodies, Monoclonal
3
2016
457
0.170
 Why?
Female
17
2018
26555
0.170
 Why?
Cells, Cultured
4
2013
1587
0.170
 Why?
Drug Resistance, Neoplasm
2
2015
314
0.170
 Why?
Syndecan-1
4
2007
72
0.160
 Why?
Genes, myc
1
2019
40
0.160
 Why?
Risk Factors
5
2018
3608
0.150
 Why?
Mice, Transgenic
4
2007
542
0.150
 Why?
Cyclin-Dependent Kinases
2
2015
26
0.150
 Why?
Oligonucleotide Array Sequence Analysis
3
2009
409
0.150
 Why?
Diffusion Magnetic Resonance Imaging
1
2018
123
0.140
 Why?
Monoclonal Gammopathy of Undetermined Significance
2
2018
111
0.140
 Why?
Hexokinase
1
2017
17
0.140
 Why?
Chromosomes, Human, Pair 17
1
2017
35
0.140
 Why?
Chromosome Aberrations
3
2016
295
0.140
 Why?
Tumor Suppressor Protein p53
2
2017
213
0.140
 Why?
Calcification, Physiologic
1
2017
40
0.140
 Why?
Proteasome Inhibitors
2
2016
104
0.140
 Why?
Pelvis
1
2017
66
0.140
 Why?
Stem Cells
2
2009
171
0.130
 Why?
Chromosome Deletion
1
2017
138
0.130
 Why?
Biopsy
2
2018
591
0.130
 Why?
Neoplasm, Residual
1
2017
156
0.130
 Why?
Neoplasms, Experimental
2
2007
111
0.130
 Why?
Male
14
2018
25427
0.130
 Why?
Pyridinium Compounds
1
2015
20
0.130
 Why?
Gene Expression Regulation, Enzymologic
1
2017
178
0.130
 Why?
Base Sequence
2
2008
657
0.130
 Why?
Fluorodeoxyglucose F18
1
2017
189
0.130
 Why?
Endothelial Cells
2
2009
256
0.130
 Why?
Homologous Recombination
1
2015
40
0.130
 Why?
Benzimidazoles
1
2015
49
0.130
 Why?
Xenograft Model Antitumor Assays
3
2015
212
0.130
 Why?
Peptide Nucleic Acids
1
2015
17
0.120
 Why?
Rad51 Recombinase
1
2015
22
0.120
 Why?
Genes, Neoplasm
1
2015
30
0.120
 Why?
Bromodeoxyuridine
2
2005
19
0.120
 Why?
Immunologic Factors
1
2016
112
0.120
 Why?
Flow Cytometry
5
2012
470
0.120
 Why?
Genomic Instability
1
2015
91
0.120
 Why?
Diphosphonates
2
2008
90
0.120
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2006
579
0.120
 Why?
Antigens, CD
1
2015
215
0.120
 Why?
Asymptomatic Diseases
1
2014
36
0.120
 Why?
Proteome
1
2015
153
0.110
 Why?
Time Factors
6
2017
2890
0.110
 Why?
Immunotherapy
1
2016
235
0.110
 Why?
Interleukin-6
2
2005
265
0.110
 Why?
Nicotinamide Mononucleotide
1
2013
3
0.110
 Why?
Acrylamides
1
2013
7
0.110
 Why?
Receptors, CXCR4
1
2013
27
0.110
 Why?
Poly(ADP-ribose) Polymerases
1
2013
29
0.110
 Why?
Niacinamide
1
2013
23
0.110
 Why?
Amides
1
2013
36
0.110
 Why?
NAD
1
2013
42
0.110
 Why?
Enzyme Induction
1
2013
79
0.110
 Why?
Proteomics
1
2015
292
0.110
 Why?
Nitriles
1
2013
52
0.110
 Why?
Sirtuin 1
1
2013
28
0.110
 Why?
Chemokine CXCL12
1
2013
30
0.110
 Why?
Enzyme Inhibitors
2
2013
378
0.110
 Why?
Recurrence
2
2012
658
0.100
 Why?
beta Catenin
1
2013
101
0.100
 Why?
Tumor Burden
2
2010
131
0.100
 Why?
Gene Knockdown Techniques
1
2013
106
0.100
 Why?
Oligopeptides
1
2013
93
0.100
 Why?
Leukemia
1
2013
64
0.100
 Why?
Myelodysplastic Syndromes
1
2013
79
0.100
 Why?
Magnetic Resonance Imaging
2
2012
1525
0.100
 Why?
Injections, Intravenous
1
2012
135
0.100
 Why?
Proto-Oncogene Proteins c-jun
2
2009
75
0.100
 Why?
Piperidines
1
2013
96
0.100
 Why?
Cytotoxicity, Immunologic
1
2012
56
0.100
 Why?
Remission Induction
1
2012
205
0.100
 Why?
Syndecans
3
2006
34
0.090
 Why?
Anti-Inflammatory Agents
1
2012
160
0.090
 Why?
Aged
8
2017
9450
0.090
 Why?
Lymph Nodes
1
2012
257
0.090
 Why?
beta 2-Microglobulin
2
2007
38
0.090
 Why?
JNK Mitogen-Activated Protein Kinases
2
2007
71
0.090
 Why?
Middle Aged
9
2018
12289
0.090
 Why?
Disease-Free Survival
3
2018
450
0.090
 Why?
Early Growth Response Protein 1
1
2009
33
0.080
 Why?
Myocardium
1
2012
443
0.080
 Why?
Dexamethasone
3
2007
424
0.080
 Why?
Sphingosine
1
2009
28
0.080
 Why?
Organoids
1
2009
36
0.080
 Why?
Lysophospholipids
1
2009
44
0.080
 Why?
Prospective Studies
5
2016
2342
0.080
 Why?
Drug Screening Assays, Antitumor
1
2009
131
0.080
 Why?
Caspases
1
2009
104
0.080
 Why?
Leukocytes, Mononuclear
1
2009
112
0.080
 Why?
p38 Mitogen-Activated Protein Kinases
1
2009
96
0.080
 Why?
Enzyme Activation
1
2009
272
0.080
 Why?
Glucuronidase
2
2007
48
0.080
 Why?
Immunoglobulin Light Chains
1
2009
82
0.080
 Why?
Lentivirus
1
2008
17
0.080
 Why?
Wnt3 Protein
1
2008
7
0.080
 Why?
Ellipticines
1
2008
2
0.080
 Why?
Wnt3A Protein
1
2008
11
0.080
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2008
67
0.080
 Why?
Bone Density Conservation Agents
1
2009
74
0.080
 Why?
B-Cell Activating Factor
1
2007
3
0.080
 Why?
Precancerous Conditions
1
2008
83
0.070
 Why?
Cytological Techniques
1
2007
14
0.070
 Why?
Diploidy
1
2007
26
0.070
 Why?
Genetic Vectors
1
2008
128
0.070
 Why?
RNA Interference
1
2008
178
0.070
 Why?
Phosphorylation
1
2009
526
0.070
 Why?
RNA, Messenger
2
2008
1099
0.070
 Why?
Karyotyping
1
2007
82
0.070
 Why?
Heparan Sulfate Proteoglycans
1
2007
11
0.070
 Why?
Hematopoietic Stem Cell Transplantation
1
2012
555
0.070
 Why?
Neoplasm Staging
2
2007
749
0.070
 Why?
Reactive Oxygen Species
1
2009
405
0.070
 Why?
Mice, Inbred C57BL
1
2012
1777
0.070
 Why?
Phenotype
2
2009
728
0.070
 Why?
Models, Animal
1
2007
227
0.070
 Why?
Immunosuppressive Agents
1
2008
226
0.070
 Why?
Carrier Proteins
2
2008
302
0.070
 Why?
Risk Assessment
3
2018
1253
0.070
 Why?
Gelatinases
1
2006
32
0.070
 Why?
Endopeptidases
1
2006
66
0.060
 Why?
Antigens, CD19
1
2005
26
0.060
 Why?
Survival Analysis
2
2018
670
0.060
 Why?
Antigens, CD34
1
2005
65
0.060
 Why?
Fetal Tissue Transplantation
1
2005
10
0.060
 Why?
Hematologic Neoplasms
1
2006
98
0.060
 Why?
Molecular Sequence Data
1
2006
799
0.060
 Why?
Endothelium, Vascular
1
2006
251
0.060
 Why?
Receptor Activator of Nuclear Factor-kappa B
1
2004
30
0.060
 Why?
Annexin A5
1
2004
13
0.060
 Why?
Culture Media, Conditioned
1
2004
48
0.060
 Why?
Phagocytosis
1
2004
49
0.060
 Why?
Clinical Trials as Topic
3
2016
466
0.060
 Why?
Neoplasm Metastasis
1
2004
235
0.060
 Why?
Membrane Proteins
1
2006
347
0.060
 Why?
Pregnancy
1
2011
2466
0.050
 Why?
Polymerase Chain Reaction
1
2005
456
0.050
 Why?
Adult
5
2018
13344
0.050
 Why?
RANK Ligand
1
2004
179
0.050
 Why?
Endothelial Growth Factors
1
2002
9
0.050
 Why?
Vascular Endothelial Growth Factors
1
2002
13
0.050
 Why?
Lymphokines
1
2002
20
0.050
 Why?
Biotransformation
1
2002
84
0.050
 Why?
Oxidative Stress
1
2007
759
0.050
 Why?
Blotting, Western
2
2015
587
0.050
 Why?
Oncogenes
1
2021
57
0.050
 Why?
Vascular Endothelial Growth Factor A
1
2002
183
0.050
 Why?
Combined Modality Therapy
2
2016
638
0.050
 Why?
Imidazoles
1
2002
128
0.050
 Why?
Chromatin
1
2021
137
0.050
 Why?
Polycomb Repressive Complex 2
1
2021
46
0.050
 Why?
Liver Transplantation
1
2002
151
0.040
 Why?
Treatment Outcome
4
2017
5174
0.040
 Why?
Histones
1
2021
295
0.040
 Why?
Protein Disulfide-Isomerases
1
2019
14
0.040
 Why?
Genes, Immunoglobulin Heavy Chain
1
2019
13
0.040
 Why?
Aged, 80 and over
2
2017
3137
0.040
 Why?
Radiography
2
2012
485
0.040
 Why?
In Situ Hybridization, Fluorescence
1
2019
256
0.040
 Why?
DNA-Binding Proteins
1
2021
424
0.040
 Why?
Tomography, X-Ray Computed
2
2017
1150
0.040
 Why?
False Positive Reactions
1
2017
60
0.040
 Why?
Metaphase
1
2016
45
0.030
 Why?
Liver
1
2002
1105
0.030
 Why?
Indolizines
1
2015
5
0.030
 Why?
Cyclic N-Oxides
1
2015
13
0.030
 Why?
Imaging, Three-Dimensional
1
2017
152
0.030
 Why?
Transcriptome
1
2018
312
0.030
 Why?
Survival Rate
1
2018
905
0.030
 Why?
Drug Synergism
1
2015
152
0.030
 Why?
S Phase
1
2015
19
0.030
 Why?
Genes, BRCA1
1
2015
19
0.030
 Why?
Follow-Up Studies
2
2013
2176
0.030
 Why?
Predictive Value of Tests
2
2007
907
0.030
 Why?
Enzyme-Linked Immunosorbent Assay
1
2015
234
0.030
 Why?
Transcription, Genetic
1
2015
370
0.030
 Why?
DNA Damage
1
2015
298
0.030
 Why?
Transfection
2
2004
354
0.030
 Why?
Interleukin Receptor Common gamma Subunit
1
2012
8
0.030
 Why?
NK Cell Lectin-Like Receptor Subfamily K
1
2012
9
0.030
 Why?
Acute Disease
1
2013
367
0.020
 Why?
Interleukin-2
1
2012
70
0.020
 Why?
Mice, Inbred NOD
1
2012
94
0.020
 Why?
Immunoenzyme Techniques
1
2012
141
0.020
 Why?
Lymphocyte Activation
1
2012
171
0.020
 Why?
Radiation-Sensitizing Agents
1
2010
51
0.020
 Why?
Incidence
1
2013
989
0.020
 Why?
Inhibitor of Apoptosis Proteins
1
2009
20
0.020
 Why?
Antibody-Dependent Cell Cytotoxicity
1
2009
12
0.020
 Why?
Protein Transport
1
2010
183
0.020
 Why?
Microtubule-Associated Proteins
1
2009
65
0.020
 Why?
Peptides
1
2010
220
0.020
 Why?
Down-Regulation
1
2009
342
0.020
 Why?
CDC2-CDC28 Kinases
1
2008
11
0.020
 Why?
Salvage Therapy
1
2008
136
0.020
 Why?
Antibodies, Monoclonal, Humanized
1
2009
223
0.020
 Why?
Protein Binding
1
2009
656
0.020
 Why?
Proteins
1
2010
347
0.020
 Why?
Antineoplastic Agents, Hormonal
1
2007
49
0.020
 Why?
Phospholipase C gamma
1
2006
4
0.020
 Why?
Cytogenetic Analysis
1
2007
80
0.020
 Why?
Cell Cycle
1
2008
226
0.020
 Why?
Caspase 9
1
2006
13
0.020
 Why?
Chi-Square Distribution
1
2007
276
0.020
 Why?
Multivariate Analysis
1
2008
579
0.020
 Why?
Mitogen-Activated Protein Kinase 3
1
2006
48
0.020
 Why?
Cyclin D
1
2006
18
0.020
 Why?
Osteoprotegerin
1
2006
52
0.020
 Why?
Bone Marrow Transplantation
1
2007
112
0.020
 Why?
Cyclins
1
2006
38
0.020
 Why?
RNA, Neoplasm
1
2006
45
0.020
 Why?
src-Family Kinases
1
2006
51
0.020
 Why?
Case-Control Studies
1
2009
1129
0.020
 Why?
Proto-Oncogene Proteins c-akt
1
2006
155
0.020
 Why?
Mice, Inbred BALB C
1
2006
296
0.020
 Why?
Chromosome Mapping
1
2006
158
0.020
 Why?
Phosphatidylinositol 3-Kinases
1
2006
139
0.020
 Why?
Cluster Analysis
1
2006
233
0.020
 Why?
Kaplan-Meier Estimate
1
2007
463
0.020
 Why?
Data Interpretation, Statistical
1
2006
159
0.020
 Why?
Transplantation, Autologous
1
2007
462
0.020
 Why?
Logistic Models
1
2007
896
0.010
 Why?
DNA, Complementary
1
2004
134
0.010
 Why?
Dose-Response Relationship, Drug
1
2007
1354
0.010
 Why?
Young Adult
1
2013
4027
0.010
 Why?
Recombinant Proteins
1
2004
482
0.010
 Why?
Randomized Controlled Trials as Topic
1
2005
550
0.010
 Why?
Solubility
1
2002
72
0.010
 Why?
Leukemia, Plasma Cell
1
2002
33
0.010
 Why?
Protein Structure, Tertiary
1
2002
249
0.010
 Why?
Adolescent
1
2013
6402
0.010
 Why?
Neoplasm Invasiveness
1
2002
268
0.010
 Why?
Retrospective Studies
1
2005
6118
0.010
 Why?
Yaccoby's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (332) concept(s)
_
Co-Authors Expand Description
See all (28) people
_
Similar People Expand Description
See all (34) people
_
Same Department Expand Description
Search Department